https://www.prnewswire.com/news-releases/fosun-pharma-received-nmpa-approval-for-wan-ti-le-tenapanor-hydrochloride-tablets-302385939.html
/PRNewswire/ -- Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma; stock code: 600196.SH, 02196.HK) announced that its holding subsidiary,...
fosun pharmareceivednmpaapprovalwan